Algert Global’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-59,310
Closed -$4.35M 1213
2025
Q3
$4.35M Buy
59,310
+10,640
+22% +$707K 0.07% 448
2025
Q2
$2.53M Buy
48,670
+40,690
+510% +$2.32M 0.05% 561
2025
Q1
$509K Sell
7,980
-2,920
-27% -$170K 0.01% 907
2024
Q4
$521K Buy
+10,900
New +$559K 0.01% 899
2024
Q3
Sell
-12,791
Closed -$670K 1346
2024
Q2
$670K Buy
+12,791
New +$561K 0.02% 797
2022
Q3
Sell
-10,272
Closed -$452K 1232
2022
Q2
$452K Sell
10,272
-49,510
-83% -$2.14M 0.03% 795
2022
Q1
$2.38M Buy
59,782
+24,464
+69% +$871K 0.16% 182
2021
Q4
$1.42M Buy
35,318
+12,913
+58% +$482K 0.18% 163
2021
Q3
$911K Buy
+22,405
New +$937K 0.12% 275
2020
Q1
Sell
-89,363
Closed -$1.58M 456
2019
Q4
$1.58M Buy
89,363
+26,801
+43% +$464K 0.47% 76
2019
Q3
$970K Sell
62,562
-3,975
-6% -$65.5K 0.36% 99
2019
Q2
$1.14M Buy
66,537
+20,572
+45% +$332K 0.42% 84
2019
Q1
$740K Sell
45,965
-52,636
-53% -$853K 0.42% 83
2018
Q4
$1.44M Buy
98,601
+33,207
+51% +$530K 0.4% 82
2018
Q3
$1.19M Buy
65,394
+22,625
+53% +$396K 0.26% 148
2018
Q2
$722K Buy
42,769
+18,939
+79% +$358K 0.15% 221
2018
Q1
$467K Buy
+23,830
New +$461K 0.09% 258
2016
Q3
Sell
-15,272
Closed -$132K 389
2016
Q2
$132K Buy
+15,272
New +$151K 0.05% 338

Other funds holding HALO

Algert Global's HALO Position: Q4 2025 in Review

Algert Global sold out of Halozyme (HALO) in Q4 2025, closing a stake of 59,310 shares — an estimated $4.35M sold.

Algert Global first reported a position in HALO in Q2 2016 and held it in 18 quarters. The position peaked at $4.35M in Q3 2025. 618 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Algert Global reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Algert Global sold 59,310 Halozyme shares in Q4 2025, an estimated $4.35M.
  • Algert Global first reported a position in Halozyme in Q2 2016 and held it in 18 quarters.
  • Algert Global's Halozyme position peaked at $4.35M in Q3 2025.
  • 618 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Algert Global's 13F filing for Q4 2025, filed 17 Feb 2026.